1. Home
  2. MCB vs ARVN Comparison

MCB vs ARVN Comparison

Compare MCB & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCB
  • ARVN
  • Stock Information
  • Founded
  • MCB 1999
  • ARVN 2015
  • Country
  • MCB United States
  • ARVN United States
  • Employees
  • MCB N/A
  • ARVN N/A
  • Industry
  • MCB Major Banks
  • ARVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • MCB Finance
  • ARVN Health Care
  • Exchange
  • MCB Nasdaq
  • ARVN Nasdaq
  • Market Cap
  • MCB 685.1M
  • ARVN 740.5M
  • IPO Year
  • MCB 2017
  • ARVN 2018
  • Fundamental
  • Price
  • MCB $75.34
  • ARVN $12.47
  • Analyst Decision
  • MCB Buy
  • ARVN Buy
  • Analyst Count
  • MCB 2
  • ARVN 23
  • Target Price
  • MCB $82.00
  • ARVN $17.80
  • AVG Volume (30 Days)
  • MCB 98.9K
  • ARVN 2.9M
  • Earning Date
  • MCB 10-23-2025
  • ARVN 11-05-2025
  • Dividend Yield
  • MCB 0.80%
  • ARVN N/A
  • EPS Growth
  • MCB 8.50
  • ARVN N/A
  • EPS
  • MCB 5.80
  • ARVN N/A
  • Revenue
  • MCB $261,456,000.00
  • ARVN $312,300,000.00
  • Revenue This Year
  • MCB $15.57
  • ARVN N/A
  • Revenue Next Year
  • MCB $13.99
  • ARVN N/A
  • P/E Ratio
  • MCB $12.96
  • ARVN N/A
  • Revenue Growth
  • MCB 1.27
  • ARVN 93.86
  • 52 Week Low
  • MCB $47.08
  • ARVN $5.90
  • 52 Week High
  • MCB $81.33
  • ARVN $27.00
  • Technical
  • Relative Strength Index (RSI)
  • MCB 64.33
  • ARVN 64.04
  • Support Level
  • MCB $67.17
  • ARVN $10.95
  • Resistance Level
  • MCB $70.46
  • ARVN $14.22
  • Average True Range (ATR)
  • MCB 2.01
  • ARVN 0.94
  • MACD
  • MCB 1.04
  • ARVN 0.10
  • Stochastic Oscillator
  • MCB 91.40
  • ARVN 59.87

About MCB Metropolitan Bank Holding Corp.

Metropolitan Bank Holding Corp is a bank holding company. It provides a broad range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area. The services provided by the company include deposits, trade finance, cash management solutions, savings, electronic banking, cards, and others. The company also provides various lending products such as acquisition loans, construction loans, and lines of credit, for retail, office, hospitality, multifamily, mixed-use, warehouse and distribution, and specialty-use properties. The bank derives its revenue in the form of interest income on loans.

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

Share on Social Networks: